Feedback / Questions
CT-0508 - CARISMA Therap
IO-202 - Immune-Onc Therap
CB-010 - Caribou Biosci
NEXI-001 - NexImmune
IO-108 - Immune-Onc Therap
NEXI-002 - NexImmune
https://www.prnewswire.com/news-releases/the-leukemia--lymphoma-society-therapy-acceleration-program-lls-tap-announces-five-new-investments-supporting-next-generation-cell-therapies-and-a-novel-immune-checkpoint-inhibitor-301274791.html
Apr 22, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next